Literature DB >> 2379498

Acceptor specificity and tissue distribution of three human alpha-3-fucosyltransferases.

R Mollicone1, A Gibaud, A François, M Ratcliffe, R Oriol.   

Abstract

Based on the capacity to transfer alpha-L-fucose onto type-1 and type-2 synthetic blood group H and sialylated acceptors, a comparison of the alpha-3-fucosyltransferase activities of different human tissues is shown. Three distinct acceptor specificity patterns are described: (I) myeloid alpha-3-fucosyltransferase pattern, in which leukocytes and brain enzymes transfer fucose actively onto H type-2 acceptor and poorly onto sialylated N-acetyllactosamine: (II) plasma alpha-3-fucosyltransferase (EC 2.4.1.152), in which plasma and hepatocyte enzymes transfer, in addition, onto the sialylated N-acetyllactosamine; (III) Lewis alpha-3 4-fucosyltransferase (EC 2.4.1.65), in which gall-bladder kidney and milk enzymes transfer, in addition, onto type-1 acceptors. The small amount (less than 10%) of alpha-3-fucosyltransferase activity found in the plasma of an alpha-3-fucosyltransferase-deficient individual had a myeloid-type acceptor pattern, suggesting that this small proportion of the plasma enzyme is derived from leukocytes. In addition to the three acceptor specificity patterns, these enzyme activities can be differentiated by their optimum pH: 8.0-8.7 for the enzymes from myeloid cells and brain. 7.2-8.0 for liver enzymes and 6.0-7.2 for gallbladder enzymes. Milk samples had two alpha-3-fucosyltransferase activities, the Lewis or alpha-3/4-fucosyltransferase under control of the Lewis gene and an alpha-3-fucosyltransferase with plasma acceptor pattern which was independent of the control of the Lewis gene. The apparent affinity for GDP-fucose of the myeloid-like enzyme was weaker than those of the plasma and Lewis-like enzymes. The apparent affinities for H type 2 and sialylated N-acetyllactosamine were stronger for exocrine secretions as compared to the plasma and myeloid enzymes. The plasma type of alpha-3-fucosyltransferase activity was more sensitive to N-ethylmaleimide and heat inactivation than the samples with myeloid-like alpha-3-fucosyltransferase activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379498     DOI: 10.1111/j.1432-1033.1990.tb19107.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  19 in total

1.  Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function.

Authors:  D C Poland; C G Schalkwijk; C D Stehouwer; C A Koeleman; B van het Hof; W van Dijk
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

2.  Activation of two new alpha(1,3)fucosyltransferase activities in Chinese hamster ovary cells by 5-azacytidine.

Authors:  B Potvin; P Stanley
Journal:  Cell Regul       Date:  1991-12

3.  Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression.

Authors:  J Sun; J Thurin; H S Cooper; P Wang; M Mackiewicz; Z Steplewski; M Blaszczyk-Thurin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

4.  Immunochemical and immunohistological expression of Lewis histo-blood group antigens in small intestine including individuals of the Le(a+b+) and Le(a-b-) nonsecretor phenotypes.

Authors:  S M Henry; B E Samuelsson; R Oriol
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

5.  Tulane virus recognizes the A type 3 and B histo-blood group antigens.

Authors:  Dongsheng Zhang; Pengwei Huang; Lu Zou; Todd L Lowary; Ming Tan; Xi Jiang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

6.  Construction of a library of human glycosyltransferases immobilized in the cell wall of Saccharomyces cerevisiae.

Authors:  Yoh-Ichi Shimma; Fumie Saito; Fumi Oosawa; Yoshifumi Jigami
Journal:  Appl Environ Microbiol       Date:  2006-08-25       Impact factor: 4.792

7.  Detailed acceptor specificities of human alpha1,3-fucosyltransferases, Fuc-TVII and Fuc-TVI.

Authors:  K Shinoda; E Tanahashi; K Fukunaga; H Ishida; M Kiso
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

8.  Evidence for two distinct alpha(1,2)-fucosyltransferase genes differentially expressed throughout the rat colon.

Authors:  J P Piau; N Labarriere; G Dabouis; M G Denis
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

9.  Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.

Authors:  Mary L Alpaugh; James S Tomlinson; Yin Ye; Sanford H Barsky
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 10.  Tumour-associated carbohydrate antigens in breast cancer.

Authors:  Aurélie Cazet; Sylvain Julien; Marie Bobowski; Joy Burchell; Philippe Delannoy
Journal:  Breast Cancer Res       Date:  2010-06-08       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.